Akero Therapeutics Correlations

AKRO Stock

USD 32.73 1.53 4.90%

The current 90-days correlation between Akero Therapeutics and Avidity Biosciences is 0.27 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Akero Therapeutics Correlation With Market

Very weak diversification

The correlation between Akero Therapeutics and DJI is 0.51 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.

Moving together with Akero Stock

0.7	MLYS	Mineralys Therapeutics,	Pair Corr
0.77	HPQ	HP Inc	Pair Corr
0.73	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.84	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.8	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr

Moving against Akero Stock

0.79	MTEM	Molecular Templates	Pair Corr
0.77	NKTX	Nkarta Inc	Pair Corr
0.76	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.69	TPST	Tempest Therapeutics	Pair Corr
0.68	VALN	Valneva SE ADR	Pair Corr
0.65	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.65	AGL	agilon health	Pair Corr
0.62	ME	23Andme Holding	Pair Corr
0.56	BACK	IMAC Holdings	Pair Corr
0.55	IPSC	Century Therapeutics	Pair Corr
0.51	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.49	TCHH	Trustcash Holdings	Pair Corr
0.45	CYRX	Cryoport	Pair Corr
0.81	EC	Ecopetrol SA ADR	Pair Corr
0.71	KO	Coca Cola Aggressive Push	Pair Corr
0.66	HYMTF	Hyundai Motor	Pair Corr
0.63	TLK	Telkom Indonesia Tbk	Pair Corr
0.58	PG	Procter Gamble	Pair Corr
0.57	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.53	SHG	Shinhan Financial	Pair Corr
0.46	VFSWW	VinFast Auto	Pair Corr
0.43	WF	Woori Financial Group	Pair Corr

Related Correlations Analysis

	TERN	MDGL	INZY	VKTX	ICPT	RETA	RVMD	RNA	PTGX	STOK
TERN		-0.44	0.73	0.17	0.43	-0.58	-0.65	-0.22	0.22	0.55	TERN
MDGL	-0.44		-0.73	-0.33	-0.12	0.7	0.75	0.01	-0.21	0.05	MDGL
INZY	0.73	-0.73		0.47	0.51	-0.69	-0.8	-0.09	0.3	0.45	INZY
VKTX	0.17	-0.33	0.47		-0.06	-0.47	-0.1	0.23	0.71	-0.07	VKTX
ICPT	0.43	-0.12	0.51	-0.06		-0.03	-0.62	-0.46	-0.33	0.75	ICPT
RETA	-0.58	0.7	-0.69	-0.47	-0.03		0.58	-0.03	-0.39	-0.01	RETA
RVMD	-0.65	0.75	-0.8	-0.1	-0.62	0.58		0.44	0.07	-0.41	RVMD
RNA	-0.22	0.01	-0.09	0.23	-0.46	-0.03	0.44		0.29	-0.28	RNA
PTGX	0.22	-0.21	0.3	0.71	-0.33	-0.39	0.07	0.29		-0.1	PTGX
STOK	0.55	0.05	0.45	-0.07	0.75	-0.01	-0.41	-0.28	-0.1		STOK
	TERN	MDGL	INZY	VKTX	ICPT	RETA	RVMD	RNA	PTGX	STOK

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RVMD	+ 0.75	MDGL
STOK	+ 0.75	ICPT
INZY	+ 0.73	TERN
PTGX	+ 0.71	VKTX
RETA	+ 0.7	MDGL
RVMD	+ 0.58	RETA

High negative correlations

RVMD	- 0.8	INZY
INZY	- 0.73	MDGL
RETA	- 0.69	INZY
RVMD	- 0.65	TERN
RVMD	- 0.62	ICPT
RETA	- 0.58	TERN

Risk-Adjusted Indicators

There is a big difference between Akero Stock performing well and Akero Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Akero Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TERN	3.37	(0.50)	0.00	(0.29)	0.00	0.00	5.68	(5.96)	34.09
MDGL	2.68	0.54	0.19	1.52	2.09	(3.60)	5.17	(3.96)	30.27
INZY	2.74	(1.09)	0.00	(0.42)	0.00	0.00	5.68	(7.92)	16.62
VKTX	3.51	(0.37)	0.00	(0.13)	0.00	0.00	6.24	(8.05)	34.61
ICPT	2.96	(0.77)	0.00	8.23	0.00	0.00	5.23	(8.32)	38.17
RETA	2.22	0.21	0.02	(1.50)	3.31	(2.35)	5.24	(3.51)	28.80
RVMD	1.99	0.30	0.13	0.39	2.04	(2.13)	4.81	(3.24)	10.95
RNA	2.85	(0.11)	(0.01)	0.05	4.19	(2.87)	5.78	(7.08)	27.94
PTGX	1.88	0.00	0.03	0.12	2.23	(1.92)	3.70	(3.74)	14.61
STOK	2.63	(0.38)	0.00	(0.17)	0.00	0.00	4.68	(6.99)	21.35

Akero Therapeutics Corporate Management

Timothy Rolph	CoFounder Officer	Profile
Patrick Lamy	Senior Strategy	Profile
Scott Gangloff	Chief Officer	Profile
Catriona Yale	Executive Officer	Profile
William JD	CFO, VP	Profile
David JD	Vice Legal	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC